Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX – Get Free Report) reached a new 52-week high on Wednesday . Negative Sentiment: Insider selling: CFO Houte Hans Van sold 4,761 shares worth approximately $116,000, while insider Gwenn Hansen sold 4,111 shares worth about $100,000. Nurix Therapeutics Price PerformanceThe company’s fifty day simple moving average is $20.80 and its two-hundred day simple moving average is $17.92. Nurix Therapeutics (NASDAQ:NRIX – Get Free Report) last released its quarterly earnings data on Thursday, July 9th. See AlsoReceive News & Ratings for Nurix Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nurix Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.